Oleclumab Uses, Dosage, Side Effects and more
Oleclumab is under investigation in clinical trial NCT03819465 (A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC).
| Trade Name | Oleclumab |
| Generic | Oleclumab |
| Oleclumab Other Names | Oleclumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
